Statistics for Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
Total visits
| views | |
|---|---|
| Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update | 3 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:81597b9a-c862-4075-8ce9-19ac0cc89c66 | 10 |
| java.util.UUID:e613eaa9-d74a-4d16-b315-0dc5eaac7623 | 10 |
| 415_2022_Article_11276.pdf | 6 |
| java.util.UUID:7ed95369-2fc3-44e3-b6c2-ac6f82b6d50d | 4 |
Top country views
| views | |
|---|---|
| United States | 3 |
Top city views
| views | |
|---|---|
| Indianapolis | 3 |